Lanata confused Chinese vaccines to criticize government

The vaccine which has the parameters mentioned by journalist Lanata It is not from Sinopharm, it is from Sinovac, which is applied in Chile and not in Argentina.

In China, three vaccines are under development, two are already sold, the Sinopharm, which was bought by the Argentine government, the Sinovac, which is the one bought by the Chileans, and the CanSino., which is under development with a Canadian laboratory, which is in an experimental phase, with phase 3 tests in Argentina.

At Argentina the vaccine is applied Sinopharm and in the next few days, a million more doses would arrive. This vaccine is 79.34% effective and the second dose can be extended for more than 28 days.

Meanwhile, the Sinovac, according to a study by researchers at the University of Chile it was concluded that with a single dose, a single dose is obtained 3% efficient, perhaps this explains the health collapse that the country is experiencing despite the fact that it has already vaccinated millions of people.